Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent
1997-08-14
2000-01-04
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
4242291, 4242321, 4352351, 4353201, A61K 39295, A61K 39275, A61K 39245, C12N 701
Patent
active
060107030
ABSTRACT:
A recombinant poxvirus vaccine against feline herpesvirus (FHV-1) is described. The recombinant poxviruses include synthetic genes encoding either a gB or gD precursor polypeptide or mixtures of the two recombinant poxviruses. The vaccine is used to provide immunity to FHV-1 in cats.
REFERENCES:
patent: 5338683 (1994-08-01), Paoletti
patent: 5494807 (1996-02-01), Paoletti et al.
Blacklaws, B.A., et al., Virology 177:727-736 (1990).
Maes, R.K., et al., J. Virol. 51:259-262 (1984).
Burgener, D.C. and R.K.Maes, American J. Vet. Res. 49:1673-1676 (1988).
Rota, P.A., et al., Virology 154:168-179 (1986).
Spear, P.G., Glycoproteins specified by herpes simples viruses.In"The Herpesviruses" (B. Roizman, ED.) vol. 3 pp. 315-356. Plenum, New York (1984).
Hutchinson, L., et al., J. Virol. 66, 2240-2250 (1992).
MacLean,C., et al., J. Gen. Virol. 72, 897-906 (1991).
Kyte, J. ad Doolittle, R., J. of Molecular Biology 157, 105-131 (1982).
Birnstiel,J., Busslinger, M. and Strub, K., Cell 41, 349-358 (1985).
Talens, L.T. and Y. Zee, Proc. Soc. Exp. Biol. Med. 151, 132-135 (1976).
Ausubel, F.,, et al., Current Protocols in Molecular Biology, J. Wiley & Sons, New York, pp. 1.7.1-1.7-2; 1.15.2-1.15.3; 4.2.1-4.2.3; and 10.8.1-10.8.6 (1988).
Sambrook, J., et al., Molecular Cloning: A Laboratory Manual. vol. II Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory (1989).
Sanger,F., Nicklen, S. and Coulson, A., Proceedings of the National Academy of Science,U.S.A. 74, 5463-5467 (1977).
Chou,P. and Fasman, G., Empirical Predictions of protein conformation. Annual Review of Biochemistry 47, 251-275 (1978).
Hammerschmidt,W., et al., Virology 165, 406-418 (1988).
Robbins, A.K., et al., J. Virol. 61, 2691-2701 (1987.
Gidoni, D., et al., Nature 12, 409-413 (1984).
Pederson,N., et al., J. Virol. 65 ,3746-3758 (1991).
Addison, C., et al., J. Gen Virol. 71, 2377-2384 (1990).
Horimoto, T., et al., Jpn. J. Vet. Sci. 51, 607-612 (1989).
Fuller and Spear, J. of Virology 55:475-482 (1985).
Spear et al., Herpes simplex virus:pathway of entry into cells. In "Cell Biology of Virus Entry, Replication and Pathogenesis" pp. 163-175 (1989).
Johnson et al., J. of Virology 64: 2569-2576 (1990).
Davison, A., Virology 186:9-14 (1992).
Noble, A., et al., Virology 129:218-224 (1983).
Johnson, D., et al., J. of Virology 62:4605-4612 (1988).
Marchioli, C., et al., J. of Virology 61: 3977-3982 (1987).
Para, M., et al., J. of Virology 55:483-487 (1985).
Iglesias, G., et al., Vet. Micro. 24: 1-10 (1990).
Britt, W., et al., J. of Virology 64: 1079-1085 (1990).
Long, D., et al., Infection and Immunity 37: 761-763 (1984).
Eisenberg, R., et al., J. of Virology 56:1014-1017 (1985).
Eloit, M.,et al., J. of Gen Virology 71: 2425-2431 (1990).
Riviere, M., et al., J. of Virology 66: 3424-3433 (1992).
van Drunen littel-van den Hurk, S., et al., J. of Gen. Virology 71:2053-2063 (1990).
Petrovskis, E., et al., J. of Virology 59: 216-223 (1986).
Ghiasi, H., et al., Arch Virology 121: 163-177 (1991).
Bernstein, D., et al., J. of Immunology 146: 3571-3577 (1991).
Rooney, J., et al., J. of Virology 62:1530-1534 (1988).
Wachsman, M., et al., J. Gen. Virology 70:2513-2520 (1989).
Wachsman, M., et al., J. of Inf. Dis. 159: 625-634 (1989).
Nakagama, H., et al., FASEB J. 5:104-108 (1991).
Zarling, J., et al., J. of Immunology 136: 4669-4673 (1986).
Reddy, P., et al., Vet. Immuno. Immunopath. 23: 62-74 (1989).
Hughes, H., et al., Immunology 74:461-466 (1991).
Hinuma, S., et al., FEBS 288,138-142 (1991).
Devereaux, J., and Grinyer, I., Nucleic Acid Research 12: 387-395 (1984).
Felsenstein, J., Evolution 39:783-791 (1985).
McGeoch, D., et al., J. Mol. Biol. 181:1-13 1985).
McGeoch, D., et al., J. Gen. Virology 69: 1531-1551 (1988).
Scott, F., Racoon poxvirus in the cat--candidate carrier virus for recombinant vaccines. In: the proceedings of the 69th conference of research workers in animal disease. Chicago,I. (1988).
Audonnet, J.C. et al. 1990. Journal of General Virology, vol.71, p. 2969-2978.
Flowers, C.C. et al. 1992. Virology, vol. 190, p. 307-315.
Petrovskis, E.A. et al. 1986. Journal of Virology, vol. 59, p. 216-223.
Ross, L.J.N. et al. 1991. Journal of General Virology, vol. 72, p. 939-947, 949-954.
Tikoo, S.K. et al. 1990. Journal of Virology, vol. 64, p. 5132-5142.
Riviere, M. et al. Journal of Virology, vol. 66, p. 3424-3434, 1992.
van Drunen Littel-van den Hurk, S. et al, Vaccine, vol. 11, p. 25-35, 1993.
Aurelian, L. et al. Reviews of Infectious Diseases, vol. 13, Suppl. 1, p. S924-S934, 1991.
Spatz et al , Journal of General Virology 57:1235-1244, 1994.
Esposito and Murphy. Advances in Veterinary Science and Comparative Medicine, vol. 33, Vaccine Biotechnology, p. 195-247, "infectious Recombinant Vectored Virus Vaccines", 1989.
Esposito, J.J et al. Virology 165: 313-316 (1988).
Maeda, K et al. Arch. Virol. 127: 387-397 (1992).
Lodmell, D et al. J. Virol. 65(6): 3400-3405 (1991).
Maes Roger K.
Spatz Stephen J.
Board of Trustees operating Michigan State University
McLeod Ian C.
Mosher Mary E.
LandOfFree
Recombinant poxvirus vaccine against feline rhinotracheitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant poxvirus vaccine against feline rhinotracheitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant poxvirus vaccine against feline rhinotracheitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1070458